Shares of Elite Pharmaceuticals Inc. (OTCMKTS:ELTP – Get Free Report) were down 4.8% during mid-day trading on Friday . The stock traded as low as $0.51 and last traded at $0.5140. Approximately 871,376 shares changed hands during mid-day trading, a decline of 28% from the average daily volume of 1,216,807 shares. The stock had previously closed at $0.54.
Elite Pharmaceuticals Trading Down 4.1%
The company has a fifty day moving average of $0.63 and a two-hundred day moving average of $0.60. The company has a current ratio of 7.23, a quick ratio of 5.44 and a debt-to-equity ratio of 0.09. The stock has a market capitalization of $556.21 million, a price-to-earnings ratio of -51.81 and a beta of 0.10.
About Elite Pharmaceuticals
Elite Pharmaceuticals, Inc, a specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals. The company operates in two segments, Abbreviated New Drug Applications for Generic Pharmaceuticals and New Drug Applications for Branded Pharmaceuticals.
See Also
- Five stocks we like better than Elite Pharmaceuticals
- ESG Stocks, What Investors Should Know
- Cloudflare Just Broke the Internet, But It’s Still a Red-Hot Buy
- 3 Warren Buffett Stocks to Buy Now
- Anthropic Just Became AI’s Hottest Ticket—Backed by Microsoft and NVIDIA
- The Basics of Support and Resistance
- Affirm Just Crushed Earnings—But Can It Outrun Klarna’s Scale?
Receive News & Ratings for Elite Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elite Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
